Bariatric Surgery vs. Semaglutide vs. Tirzepatide — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bariatric Surgery vs. Semaglutide vs. Tirzepatide — Stella

Home/Obesity and Obesity-related Medical Conditions/

View on ClinicalTrials.gov

Recruiting

Back to Obesity and Obesity-related Medical Conditions trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

The Cleveland Clinic, Cleveland, Ohio

Key details

Phase

Post-approval study

Sponsor

Ali Aminian

Collaborators

Ethicon, Inc.

Enrollment target

~125 participants

Started

January 2025

Primary completion

July 2027

Age range

18 Years – 70 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.